ISSN: 1473-7159

Journal Home

Journal Guideline

Expert Review of Molecular Diagnostics Q1 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Expert Review of Molecular Diagnostics is a journal indexed in SJR in Molecular Biology and Pathology and Forensic Medicine with an H index of 89. It has a price of 4000 €. It has an SJR impact factor of 0,823 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,823.

Expert Review of Molecular Diagnostics focuses its scope in these topics and keywords: cancer, clinical, current, personalized, biomarkers, molecular, oncologyimmunohistochemistrybased, profiling, prognostic, developments, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pathology and Forensic Medicine (Q1) Genetics (Q2) Molecular Biology (Q2) Molecular Medicine (Q2)

Price

4000 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,823

SJR Impact factor

89

H Index

119

Total Docs (Last Year)

343

Total Docs (3 years)

9576

Total Refs

1301

Total Cites (3 years)

292

Citable Docs (3 years)

3.43

Cites/Doc (2 years)

80.47

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cell Research Q1
Molecular Cell Q1
Cell Host and Microbe Q1
Annual Review of Plant Biology Q1
Journal of Hematology and Oncology Q1

Compare this journals

Aims and Scope

Best articles by citations

Biomarkers research in Europe: focus on personalized medicine

OraQuick¬Æ ADVANCE Rapid HIV-1/2 antibody test

Applications of electrowetting-based digital microfluidics in clinical diagnostics

Laser Capture Microdissection: a rising tool in genetic profiling of cancer

Innovation versus evidence: to trust direct-to-consumer personal genomic tests?

Molecular methods for rapid detection of group B streptococci

Translating potential biomarker candidates for schizophrenia and depression to animal models of psychiatric disorders

Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention

What if we could amplify DNA in vitro?

Evaluation of the Cepheid Xpert MTB/RIF assay

Diagnostic value of real-time capillary thermal cycler in virus detection

Current and future molecular diagnostics of gastric cancer

SHOW MORE ARTICLES

Application of automation and information systems to forensic genetic specimen processing

Protein microarrays in diagnosing IgE-mediated diseases: spotting allergy at the molecular level

Oncologic theranostics: recognition of this concept in antigen-directed cancer therapy for colorectal cancer with anti-TAG-72 monoclonal antibodies

Genetic testing in chronic pancreatitis

New developments in the diagnosis of maternal and congenital CMV infection

The national biomarker development alliance: confronting the poor productivity of biomarker research and development

Current and future trends in biomarker discovery and development of companion diagnostics for arthritis

Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer

Signature of a silent killer: expression profiling in epithelial ovarian cancer

Role of ProstaScint¬Æ for brachytherapy in localized prostate adenocarcinoma

Hepatitis C virus RNA assays: current and emerging technologies and their clinical applications

Overcoming tumor heterogeneity in the molecular diagnosis of urological cancers